{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:19:27Z","timestamp":1768623567376,"version":"3.49.0"},"reference-count":17,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s436041","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T04:30:12Z","timestamp":1705638612000},"page":"207-216","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to Background Antipsychotic and Pimavanserin in Patients with Schizophrenia: Post Hoc Analyses from the ENHANCE and ADVANCE Studies"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Dragana","family":"Bugarski-Kirola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Abbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzey","family":"Odetalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryl","family":"DeKarske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/wps.20060","volume":"12","author":"Kane","year":"2013","journal-title":"World Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref5","unstructured":"US Food and Drug Administration. Enrichment Strategies for Clinical Trials to Support Demonstration of Effectiveness of Human Drugs and Biological Products. Silver Spring, Maryland: FDA; 2019."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgac006","volume":"3","author":"Bugarski-Kirola","year":"2022","journal-title":"Schizophr Bull Open"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2215-0366(21)00386-2","volume":"9","author":"Bugarski-Kirola","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40263-020-00713-9","volume":"34","author":"Yaegashi","year":"2020","journal-title":"CNS Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.4088\/jcp.v67n0715","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3111\/13696998.2013.816310","volume":"16","author":"Lang","year":"2013","journal-title":"J Med Econ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/070674370905400106","volume":"54","author":"Rabinovitch","year":"2009","journal-title":"Can J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12888-018-1737-4","volume":"18","author":"Stentzel","year":"2018","journal-title":"BMC Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1530-0277.2007.00343.x","volume":"31","author":"Baros","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1093\/schbul\/sbz022.133","volume":"45","author":"Brannan","year":"2019","journal-title":"Schizophr Bull"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2147\/PPA.S242693","volume":"14","author":"De Las Cuevas","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/PPA.S212046","volume":"13","author":"Shahin","year":"2019","journal-title":"Patient Prefer Adherence"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=96082","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=96082","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T04:30:14Z","timestamp":1705638614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/adherence-to-background-antipsychotic-and-pimavanserin-in-patients-wit-peer-reviewed-fulltext-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2147\/ppa.s436041","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}